FOXBOROUGH, Mass. – R&D Magazine today named the BrainGate Neural Interface System one of the top 100 most innovative new products of the year. BrainGate is an interface between a patient’s brain and a computer created by Cyberkinetics Neurotechnology Systems that is designed to control assistive devices by neural signaling.
The technology is in clinical trials with people who have severe paralysis due to spinal core injury, stroke and ALS (Lou Gehrig’s disease), and was developed based on work done by Cyberkinetics’ chief scientific officer, John P. Donoghue, who is also the director of the Brain Science Program at Brown University (for more on the subject, go to Brown team developing new tools for thought).
“We are honored to be picked for this prestigious industry award,” stated Timothy R. Surgenor, president and CEO of Cyberkinetics, in a statement. “It reflects the achievements of our work in neural signaling technology and its potential to significantly improve the quality of life for people with severe paralysis.”
Battelle, the world’s largest nonprofit independent research and development organization, is co-winner of the award with Cyberkinetics.
The R&D 100 winners are chosen by an independent panel of judges; past winners of the competition, which started in 1963, include the automated teller machine, the Nicoderm anti-smoking patch and high-definition television.
Cyberkinetics Neurotechnology Systems Inc. is developing neural stimulation, sensing and processing technology designed to improve the lives of those with severe paralysis. For more information, go to www.cyberkinetics.com.
Batelle Medical Device Solutions delivers support services to medical device, biotechnology and pharmaceutical firms in multiple markets; it is a division of Batelle, a company that conducts $3.7 billion in research and development work annually. For more information, go to www.batelle.org.
